Latest filing published 14 Mar 2025 for Repare Therapeutics Inc., €2,475.
Daniel Bélanger appears in our data through filings on Repare Therapeutics Inc. shares, published by SEC (Form 4). In total, 3 filings cover trades dated from 9 May 2023 to 13 March 2025.
No open-market purchase appears, only 1 sale worth €1,303. Besides market trades, the filings include 1 option exercise. Since January 2025: no purchases and 1 sale on the market.
The latest filing, published on 14 March 2025, reports an option exercise of €2,475 in Repare Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations